Note: Ingredients listed on restricted chemical lists
EC/CAS
7783-28-0
Name of the chemical
Diammonium-hydrogenorthophosphate
Concentration
N/A
General Information
Revision date
2016-03-23
Product name
DAP (100% SOLUBLE)
CAS No.
7783-28-0
supplier name
QUADRA CHEMICALS LTD
Icons in SDS
Company Information
company name
QUADRA CHEMICALS LTD
Section 2
SECTION 2: Hazards identification
Physical state Solid. [Crystals.] Odor : Odorless. Emergency overview MAY CAUSE RESPIRATORY TRACT, EYE AND SKIN IRRITATION. Slightly irritating to the eyes, skin and respiratory system. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat. Avoid breathing dust. Avoid contact with eyes. Avoid prolonged or repeated contact with skin. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling.
Principle Routes of Exposure
Inhalation. Ingestion.
Potential Acute Health Effects
Inhalation Slightly irritating to the respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion No known significant effects or critical hazards. Skin Slightly irritating to the skin. Eyes Slightly irritating to the eyes.
Potential chronic health
effects : Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Not available. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: irritation watering redness Medical conditions : None known. aggravated by over- exposure See toxicological information (section 11) 3 .